BL/BLI combinations in phase-I trials (Table 
funobactam
Nacubactam (Xeruborbactam (A combination of the DBO-type BLI ETX0282 (A ledaborbactam etzadroxil (A ternary combination therapy combining funobactam (CTB + AVP (PF-07612577; po) is a combination of the cephalosporin ceftibuten (